OakChart

Diversified Healthcare Trust

DHCReal Estate·REIT - Healthcare Facilities·USA·Small·NASD·Nov 11 • 7:10 AM ET

7.50+0.10 (1.35%)
2026-11-11 14:47 CET
Market cap
1,794.71 USD m
Revenue, TTM
1,479.10 USD m
Net income, TTM
-152.14 USD m
Free cash flow, TTM
-16.25 USD m
EPS diluted, TTM
-0.63
P/E
-
Compare

Price

DHC against its 20, 50 and 200-day averages
2050200miss
6.007.008.009.002.7M5.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26DHCclose 7.5020-day 7.5950-day 7.69200-day 7.847.50

22.4% under 9.66 on 30 Jun 2026. Last 15 sessions, 19.7% high to low

Profile

DHC
52-week range, 59% of the way up
4.349.66

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the Medical Office and Life Science Portfolio and SHOP segments. The Medical Office and Life Science Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. The SHOP segment manages senior living communities that provide short term and long-term residential living and, in some instances, care and other services for residents where pay fees to managers to operate the communities. The company was founded on December 16, 1998 and is headquartered in Newton, MA.

IndexRUT
IPOOct 07, 1999
Beta2.29
ATR, 14d0.29
Rel volume0.00
Short float5.51%
Insider own10.24%
Inst own84.68%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.82B
Enterprise Value4.11B
Income-152.14M
Sales1.48B
Book/sh6.31
Cash/sh0.54
Dividend Est.0.04 (0.53%)
Dividend TTM0.04 (0.53%)
Dividend Ex-DateOct 19, 2026
Dividend Gr. 3/5Y0.00% -25.98%
Payout-
Employees-
IPOOct 07, 1999

Ratios

P/E-
Forward P/E-
PEG-
P/S1.23
P/B1.19
P/C13.89
P/FCF-
EV/EBITDA17.55
EV/Sales2.78
Quick Ratio8.88
Current Ratio8.88
Debt/Eq1.58
LT Debt/Eq1.58
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.63
EPS next Y-0.40
EPS next Q-0.14
EPS this Y44.26%
EPS next Y39.20%
EPS next 5Y31.65%
EPS past 3/5Y-161.94% -15.19%
Sales past 3/5Y6.21% -1.18%
EPS Y/Y TTM56.90%
Sales Y/Y TTM-3.82%
EPS Q/Q69.46%
Sales Q/Q-5.41%
EarningsNov 02 AMC
EPS/Sales Surpr.184.00% -0.86%

Ownership

Insider Own10.24%
Insider Trans0.00%
Inst Own84.68%
Inst Trans5.36%
ROA-3.43%
ROE-9.45%
ROIC-3.85%
Gross Margin4.28%
Oper. Margin-1.11%
Profit Margin-10.29%
SMA20-1.15%
SMA50-2.49%
SMA200-4.31%
Trades-

Technical

Shs Outstand242.56M
Shs Float217.70M
Short Float5.51%
Short Ratio6.57
Short Interest11.99M
52W High9.66 -22.36%
52W Low4.34 72.81%
Volatility5.55% 3.89%
ATR (14)0.29
RSI (14)47.47
Beta2.29
Rel Volume0.00
Avg Volume1.83M
Volume6

Performance

Perf Week1.76%
Perf Month-1.57%
Perf Quarter-10.39%
Perf Half Y-14.09%
Perf YTD54.64%
Perf Year64.11%
Perf 3Y262.32%
Perf 5Y111.86%
Perf 10Y-56.08%
Recom1.80
Target Price9.88
Prev Close7.40
Price7.50
Change %1.35%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
Apr 27, 2026InitiatedMMaxim GroupBuy$9.50+26.7%
Nov 13, 2025UpgradeRRBC Capital MktsUnderperform → Sector Perform$5-33.3%
Apr 03, 2025ResumedRB. Riley SecuritiesBuy$4.50-40.0%
Dec 10, 2020DowngradeWWells FargoEqual Weight → Underweight$4-46.7%
Jun 08, 2020ResumedJJMP SecuritiesMkt Perform
Jan 17, 2020DowngradeWWells FargoOverweight → Equal Weight$9+20.0%

Peers

Mkt cap
TickerCompanyMkt cap
AHRAmerican Healthcare REIT Inc14.25B
NHINational Health Investors Inc3.33B
VTRVentas Inc48.97B
LTCLTC Properties Inc2.56B
SBRASabra Healthcare REIT Inc5.59B
WELLWelltower Inc180.47B
NHPNational Healthcare Properties Inc1.09B
DOCHealthpeak Properties Inc14.42B
HRHealthcare Realty Trust Inc6.55B
JANJanus Living Inc10.20B

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Bilotto Christopher J.President and CEODec 15 '25Buy4.8920,00097,720266,285Dec 16 04:44 PM

Held by

AUM
TickerCompanyAUM
VNQVanguard Real Estate Index Fund ETFAUM: 39.03B
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
IWMiShares Russell 2000 Index FundAUM: 78.30B
VXFVanguard Extended Market Index ETFAUM: 30.61B
IWNiShares Russell 2000 Value ETFAUM: 14.17B
SCHHSchwab U.S. REIT ETFAUM: 11.39B
VTWOVanguard Russell 2000 Index ETFAUM: 16.97B
DFARDFA Real Estate Securities Portfolio ETF Class SharesAUM: 1.82B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.85B
SCHASchwab U.S. Small-Cap ETFAUM: 22.32B

News

latest 14 of 206
  • Diversified Healthcare Trust Misses And Cuts FFO Guidance, But The Cut Is An Accounting Change While SHOP Fundamentals Improve (Earnings Whispers)
  • Diversified Healthcare: Q3 Earnings Snapshot (Associated Press)
  • Diversified Healthcare Trust Announces Third Quarter 2026 Results (Business Wire)
  • Diversified Healthcare Trust Must Show Its Margin Story Can Survive Slower Occupancy Gains (Earnings Whispers)
  • The RMR Group Announces $272 Million Refinancing of Cedars-Sinai Medical Office Portfolio in Los Angeles (Business Wire)
  • Loading…
  • Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares (Business Wire)
  • Diversified Healthcare Trust Third Quarter 2026 Conference Call Scheduled for Tuesday, November 3rd (Business Wire)
  • Diversified Healthcare Trust Announces 15-Year Net Lease with The Ensign Group for Colorado Skilled Nursing Portfolio (Business Wire)
  • Industrial Logistics Properties Trust Appoints Anthony Paula as Chief Financial Officer and Treasurer (Business Wire)
  • Diversified Healthcare Trust (DHC) (Q2 2026) Earnings Call Highlights: SHOP NOI Surges 37% as ... (GuruFocus.com)
  • Diversified Healthcare: Q2 Earnings Snapshot (Associated Press)
  • Diversified Healthcare Trust Announces Second Quarter 2026 Results (Business Wire)
  • Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-020.126-0.150-0.210367.67370.873
2026Q22026-08-03-0.160-0.147-0.155365.39370.763
2026Q12026-05-04-0.180-0.157-0.180366.47380.183
2025Q42026-02-23-0.090-0.175-0.088379.57392.892
2025Q32025-11-030.043-0.215-0.682388.71382.312
2025Q22025-08-040.079-0.220-0.382382.71380.622
2025Q12025-05-050.057-0.250-0.037386.86383.172
2024Q42025-02-25-0.360-0.290-0.364379.62370.971
2024Q32024-11-040.019--0.412373.64380.17-
2024Q22024-08-01-0.442-0.280-0.409371.39372.131
2024Q12024-05-06-0.343-0.280-0.361370.78370.651
2023Q42024-02-26-0.325-0.250-0.429361.54360.991
2023Q32023-11-01-0.264--0.275356.52359.78-
2023Q22023-08-01-0.287-0.220-0.304346.22353.151
2023Q12023-05-08-0.193-0.230-0.221346.03341.331
2022Q42023-03-01-0.237-0.280-0.274336.89330.41

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY0.4420.5020.6221,0751,074
2018FY1.1741.8851.2081,1171,120
2019FY-0.370-0.130-0.3711,0401,036
2020FY-0.378-0.653-0.5871,6321,636
2021FY-1.088-1.0400.7331,3831,382
2022FY-1.201-0.070-0.0661,2841,277
2023FY-1.128-1.050-1.2291,4101,410
2024FY-1.550-1.470-1.5461,4951,486
2025FY-1.190-1.275-1.1901,5381,551
2026FY--0.663--1,475
2027FY--0.403--1,547
2028FY--0.380--1,652

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-06502373.28363382.14
2026Q4S2026-11-03502373.07363381.12
2026Q4S2026-11-02502373.81365.4381.12
2026Q4S2026-10-19501375.56365.4384.98
2026Q4S2026-10-18502375.56365.4384.98
2026Q4S2026-08-22504375.56365.4384.98
2026Q4S2026-08-20505375.56365.4384.98
2026Q4S2026-08-05505379.36365.4396.3
2026Q4S2026-08-04504382.13365.4396.3
2026Q4S2026-07-19502386.93370.4396.3
2026Q4S2026-06-16504386.93370.4396.3
2026Q4S2026-06-08403384.59370.4394.97
2026Q4S2026-06-07302384.46370.4394.97
2026Q4S2026-05-13502393.4370.4414.2

Estimate history

EPS, annual0.6221.208-0.371-0.5870.733-0.066-1.229-1.546-1.19-0.6318
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.412-0.364-0.037-0.382-0.682-0.088-0.18-0.155-0.208
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual409.224430.7531040.1551632.0261383.2121283.5661410.3081495.4271537.8531479.1
Period201720182019202020212022202320242025TTM
Sales, quarterly373.64379.619386.864382.712388.706379.571366.471365.387367.67
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual237.63237.73237.897238.268238.995239.695240.424241.272242.121242.564
Period201720182019202020212022202320242025MRQ
Shares, quarterly241.281241.272241.268241.42242.147242.121242.109242.189242.564
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,479.101,537.851,495.431,410.311,283.571,383.211,632.031,040.15430.75
Total Expenses1,495.511,577.121,550.531,487.091,403.051,456.771,503.81828.23844.62
Operating Income-16.41-39.27-55.10-76.78-119.48-73.56128.22211.93-413.87
Unusual Expense-9.41200.7171.0619.2725.722.2484.50115.2566.37
Net Income Before Taxes-180.75-320.90-371.38-272.67-21.12181.36-133.06-82.84292.37
Income Taxes3.161.740.470.450.711.431.250.440.48
Consolidated Net Income-152.14-285.89-370.25-293.57-15.77179.93-134.31-82.88292.41
Net Income From Continuing Operations-152.14-285.89-370.25-293.57-15.77174.51-139.45-88.23286.87
Net Income-152.14-285.89-370.25-293.57-15.77174.51-139.45-88.23286.87
EPS (Recurring)-0.66-0.61-1.34-1.170.010.74-0.34-0.031.40
EPS (Basic, Before Extraordinaries)-0.63-1.19-1.55-1.23-0.070.73-0.59-0.371.21
EPS (Diluted)-0.63-1.19-1.55-1.23-0.070.73-0.59-0.371.21
Non-Operating Income (Expense)13.39123.53-9.9915.16333.46512.9124.710.58265.48
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-2.692.171.451.371.431.140.83-1.33
Price To Earnings Ratio----0.374.22--108.19
Price To Sales Ratio1.280.760.370.630.120.530.601.936.46
Gross Margin4.281.08-1.74-3.40-5.051.477.6925.19-71.29
Operating Margin-1.11-2.55-3.68-5.44-9.31-5.327.8620.37-96.08
Net Margin-10.29-18.59-24.76-20.82-1.2312.62-8.54-8.4866.60
Shares Outstanding242.56242.12241.27240.42239.69238.99238.27237.90237.73
Market Capitalization1,794.711,794.71554.93899.28155.04738.49981.661,948.062,703.21

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue367.67365.39366.47379.57388.71382.71386.86379.62
Total Expenses367.71365.90371.20390.69404.66390.10391.68391.71
Operating Income-0.04-0.52-4.73-11.12-15.95-7.39-4.81-12.09
Unusual Expense-14.540.000.005.13104.4331.1260.0229.13
Net Income Before Taxes-52.21-37.97-42.75-47.81-168.79-93.88-10.42-98.96
Income Taxes0.721.300.620.510.340.840.05-0.04
Consolidated Net Income-50.23-37.42-43.27-21.22-164.04-91.64-8.99-87.45
Net Income From Continuing Operations-50.23-37.42-43.27-21.22-164.04-91.64-8.99-87.45
Net Income-50.23-37.42-43.27-21.22-164.04-91.64-8.99-87.45
EPS (Recurring)-0.25-0.16-0.18-0.07-0.38-0.290.14-0.28
EPS (Basic, Before Extraordinaries)-0.21-0.16-0.18-0.09-0.68-0.38-0.04-0.36
EPS (Diluted)-0.21-0.16-0.18-0.09-0.68-0.38-0.04-0.36
Non-Operating Income (Expense)-0.50-0.41-0.9915.280.49-4.45112.241.77
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Price To Sales Ratio1.281.491.050.760.690.560.380.37
Gross Margin4.875.993.552.77-0.521.011.09-3.44
Operating Margin-0.01-0.14-1.29-2.93-4.10-1.93-1.24-3.18
Net Margin-13.66-10.24-11.81-5.59-42.20-23.94-2.32-23.04
Shares Outstanding242.56242.19242.11242.12242.15241.42241.27241.27
Market Capitalization1,794.712,251.601,607.681,174.411,064.64863.68578.97554.93

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments121.80149.85246.96688.301,016.9590.8552.2270.0747.32
Short Term Receivables66.1473.8781.3985.0882.130.001.9918.7018.54
Investments3,858.904,340.484,797.624,870.075,107.295,789.605,892.366,483.946,533.04
Investment in Unconsolidated Affiliates147.33155.50136.00164.19215.130.010.300.028.19
Net Property, Plant & Equipment16.5420.0223.3726.510.000.000.000.000.00
Other Intangible Assets150.55397.27160.80167.94197.87591.73706.96587.70686.94
Total Assets4,361.255,137.015,446.146,002.096,623.516,476.426,653.837,160.437,294.02
Total Debt2,417.942,931.612,841.073,075.883,683.433,571.053,578.373,734.723,770.54
Long Term Debt2,416.072,549.672,839.252,809.473,644.363,267.893,124.573,288.583,770.54
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities277.74246.55268.18287.60277.69286.15198.41245.84246.29
Total Liabilities2,695.683,178.163,109.243,363.483,961.123,857.203,776.783,980.564,016.83
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,665.571,958.842,336.892,638.612,662.392,495.842,736.523,023.113,104.95
Total Shareholders Equity1,665.571,958.842,336.892,638.612,662.392,495.842,736.523,023.113,104.95
Accumulated Minority Interest0.000.000.000.000.00123.39140.53156.76172.24
Total Equity1,665.571,958.842,336.892,638.612,662.392,619.222,877.053,179.873,277.19
Total Liabilities & Stockholders Equity4,361.255,137.015,446.146,002.096,623.516,476.426,653.837,160.437,294.02
Book Value Per Share6.888.129.7211.0111.1410.4711.5012.7213.07
Tangible Book Value Per Share6.798.019.5810.8210.949.2710.0810.9511.08
Price to Book Ratio1.170.270.370.060.280.390.710.891.42
Return on Assets-6.02-7.00-5.13-0.252.66-2.12-1.283.972.03
Return on Equity-15.78-17.24-11.80-0.606.77-5.33-3.069.364.68
Return on Invested Capital-7.00-8.21-5.67-0.292.77-2.42-1.514.552.15
Quick Ratio3.711.1910.642.5714.240.570.530.170.78
Current Ratio3.711.1910.642.5714.240.570.530.170.78

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Funds from Operations81.10-4.48105.4138.32-41.991.80172.01323.16389.74
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital21.3033.266.82-27.841.64-65.12-13.18-50.883.10
Cash from Operating Activities102.4128.78112.2210.48-40.35-63.31158.83272.27392.84
Capital Expenditures-118.66-146.82-201.70-235.01-299.39-227.60-185.59-222.42-103.80
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.0098.560.00
Purchase or Sale of Investments225.83580.7328.4418.36672.63470.29144.86203.60202.90
Purchase of Investments-14.52-8.50-5.720.00-75.110.00-2.53-50.64-129.49
Sale Or Maturity of Investments240.34589.2334.1718.36747.73470.29147.39254.24332.39
Other Uses-0.19-0.05-15.460.000.000.000.000.000.00
Other Sources0.001.311.7014.5414.470.000.000.000.00
Cash from Investing Activities106.98435.17-187.02-202.11387.71242.69-40.7279.7599.09
Cash Dividends Paid-9.68-9.66-9.63-9.60-9.57-9.54-42.83-199.72-370.75
Change in Capital Stock-2.78-1.15-0.90-0.39-0.17-0.38-0.17-0.30-0.41
Repurchase of Common Pref Stock-2.78-1.15-0.90-0.39-0.17-0.38-0.17-0.30-0.41
Sale of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-269.65-443.54-11.78-238.75-639.07778.99-13.82-1,142.35384.44
Change in Long Term Debt480.35310.31-8.56478.30-639.070.00-542.88-696.00-
Issuance of Long Term Debt-372.40320.93111.44728.300.000.00425.12--
Reduction of Long Term Debt852.74-10.62-120.00-250.00-639.070.00-968.00-696.00-
Net Financing Active Other Cash Flow-0.250.000.000.00-27.19-32.70-22.67-21.58-21.17
Other Financing Activities Uses-2.11-37.660.00-0.98-27.19-32.70-22.67-21.58-21.17
Cash from Financing Activities-288.06-492.01-22.31-249.71-676.00746.72-79.48-369.86-469.18
Net Change in Cash-78.68-28.05-97.11-441.34-328.64926.1038.62-17.8522.75
Free Cash Flow-16.25-118.04-89.48-224.52-339.74-290.92-26.7549.85289.04
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments130.95136.20139.85121.80209.62148.58
Short Term Receivables61.9162.0262.2266.1462.0669.75
Investments3,717.823,936.563,818.893,858.903,882.364,153.64
Investment in Unconsolidated Affiliates122.98120.87119.62147.33121.01147.57
Net Property, Plant & Equipment13.8014.7215.6416.5417.4218.30
Other Intangible Assets141.96-31.67111.34150.55391.50218.60
Total Assets4,189.414,238.704,267.554,361.254,683.974,756.44
Total Debt2,418.222,417.932,417.592,417.942,741.182,655.20
Long Term Debt2,417.912,417.322,416.522,416.072,405.752,655.20
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities241.30237.93229.54277.74254.07246.27
Total Liabilities2,659.522,655.872,647.132,695.682,995.242,901.47
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,529.881,582.831,620.421,665.571,688.731,854.97
Total Shareholders Equity1,529.881,582.831,620.421,665.571,688.731,854.97
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,529.881,582.831,620.421,665.571,688.731,854.97
Total Liabilities & Stockholders Equity4,189.414,238.704,267.554,361.254,683.974,756.44
Book Value Per Share6.316.546.696.886.977.68
Tangible Book Value Per Share6.236.466.616.796.887.59
Price to Book Ratio1.171.390.970.700.570.44
Return on Assets-3.43-5.91-6.91-6.02-7.06-5.68
Return on Equity-9.45-15.47-17.94-15.78-18.84-14.32
Return on Invested Capital-1.27-0.94-1.07-0.52-4.01-2.03
Quick Ratio8.886.657.753.711.4510.88
Current Ratio8.886.657.753.711.4510.88

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Funds from Operations29.6628.3623.43-0.35-32.7530.27
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-2.2710.02-15.0828.64-16.5422.75
Cash from Operating Activities27.3938.388.3428.29-49.2853.02
Capital Expenditures-26.87-24.18-35.17-32.43-40.56-34.18
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.00-14.5648.89191.5046.6713.13
Purchase of Investments0.00-14.560.000.050.00-2.75
Sale Or Maturity of Investments0.000.0048.89191.4546.6715.87
Other Uses0.000.00-0.15-0.050.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-26.87-38.7513.58159.026.12-21.05
Cash Dividends Paid-2.42-2.42-2.42-2.42-2.41-2.41
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-2.56-0.05-0.09-0.08-0.95-0.10
Repurchase of Common Pref Stock-2.56-0.05-0.09-0.08-0.95-0.10
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.79-0.82-1.36-270.77117.48-187.52
Change in Long Term Debt0.000.000.00480.35118.55-186.70
Issuance of Long Term Debt0.000.000.00-372.40363.36193.30
Reduction of Long Term Debt0.000.000.00852.74-244.81-380.00
Net Financing Active Other Cash Flow0.00-0.08-0.170.000.000.00
Other Financing Activities Uses0.00-0.08-0.17-1.86-9.900.00
Cash from Financing Activities-5.77-3.29-3.87-275.13104.21-190.04
Net Change in Cash-5.25-3.6618.05-87.8261.04-158.07
Free Cash Flow0.5214.20-26.82-4.14-89.8418.84

Revenue breakdown

Rental Income2024: 251.04M 2025: 225.20M
Resident Fees And Services2024: 1.24B 2025: 1.31B
United States2024: 1.50B 2025: 1.54B
Consolidation, Policy2024: 37.72M 2025: 31.39M
Medical Office and Life Science Portfolio2024: 213.32M 2025: 193.81M
Senior Housing Operating Portfolio2024: 1.24B 2025: 1.31B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.51%12.0M217.7M1.85M
2026-10-155.40%11.7M217.3M1.82M
2026-09-305.38%11.7M217.3M1.68M
2026-09-156.17%13.4M217.3M1.67M
2026-08-315.94%12.9M217.5M1.75M
2026-08-146.08%13.2M217.5M1.86M
2026-07-316.30%13.7M217.5M1.73M
2026-07-155.75%12.5M217.4M1.72M
2026-06-305.58%12.1M217.4M1.77M
2026-06-154.78%10.2M212.4M1.79M
2026-05-293.96%8.6M217.5M1.85M
2026-05-154.30%9.3M217.5M1.91M
2026-04-304.51%9.8M217.5M1.94M
2026-04-154.32%9.4M217.0M2.11M
2026-03-314.02%8.7M217.0M2.10M
2026-03-133.47%7.5M217.0M1.83M
2026-02-272.87%6.2M217.0M1.54M
2026-02-132.53%5.5M216.9M1.34M
2026-01-302.70%5.9M217.5M1.23M
2026-01-152.74%6.0M217.5M970.74K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.502.906.600.0015.7500.000.000.978-0.0130.001
call5.000.504.102.207.2161.000.000.946-0.0110.001
call7.500.001.101.602.3652.000.000.558-0.0540.005
call10.000.000.150.031.4481.000.000.126-0.0190.003
call12.500.001.100.001.8500.000.000.058-0.0130.001
call15.000.001.850.002.3250.000.000.049-0.0150.001
put2.500.001.850.003.9190.000.00-0.022-0.0130.001
put5.000.001.300.021.6241.000.00-0.054-0.0110.001
put7.500.101.000.051.9631.000.00-0.442-0.0530.005
put10.001.054.600.005.7570.000.00-0.874-0.0180.003
put12.503.407.100.006.6970.000.00-0.942-0.0120.001
put15.005.909.600.007.3920.000.00-0.951-0.0130.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0210-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-028-KCurrent report2026-11-02SEC
2026-09-214Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-214Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-214Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-12SCHEDULE 13D/ASEC
2026-08-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-07-28SCHEDULE 13G/ASEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-128-KCurrent report2026-06-10SEC
2026-06-018-KCurrent report2026-06-01SEC
2026-05-058-KCurrent report2026-05-05SEC
2026-05-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-048-KCurrent report2026-05-04SEC
2026-03-26SCHEDULE 13G/ASEC
2026-03-25DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-03-19DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-03-19DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-10SEC
2026-03-19ARSAnnual report to security holders. 2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-1297.72K100
2025-110000

Institutional holders

Manager% owned
Flat Footed LLC9.70%
BlackRock, Inc.9.53%
Silver Point Capital L.P.6.40%
H/2 CREDIT MANAGER LP5.29%
VANGUARD PORTFOLIO MANAGEMENT LLC4.38%
VANGUARD CAPITAL MANAGEMENT LLC4.00%
STATE STREET CORP3.72%
GEODE CAPITAL MANAGEMENT, LLC2.89%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP2.65%
NOMURA HOLDINGS INC2.59%

Funds

Fund% owned
Lord Abbett Short Duration High Yield Fund7.31%
Intrepid Income Fund6.61%
PGIM Total Return Bond Fund4.99%
iShares Broad USD High Yield Corporate Bond ETF4.23%
BlackRock High Yield Portfolio4.01%
Lord Abbett High Yield Fund3.91%
PIMCO High Yield Fund3.31%
iShares iBoxx $ High Yield Corporate Bond ETF3.31%
VANGUARD REAL ESTATE INDEX FUND3.14%
PGIM Floating Rate Income Fund3.11%

OakChart. DHC. Cached 15 minutes.